- Home
- ACT vs XENE Comparison
ACT vs XENE Comparison
Compare ACT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACT | XENE |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.2B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ACT | XENE |
|---|---|---|
| Price | $45.77 | $60.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $44.25 | ★ $68.55 |
| AVG Volume (30 Days) | 296.5K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | ★ 3.43 | N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $1,235,827,000.00 | $311,000.00 |
| Revenue This Year | $4.06 | N/A |
| Revenue Next Year | $2.33 | $2,496.48 |
| P/E Ratio | $38.60 | ★ N/A |
| Revenue Growth | ★ 2.83 | N/A |
| 52 Week Low | $33.94 | $30.00 |
| 52 Week High | $45.65 | $62.91 |
Technical Indicators
Market Signals| Indicator | ACT | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 70.88 | 72.74 |
| Support Level | $41.97 | $52.40 |
| Resistance Level | N/A | $62.91 |
| Average True Range (ATR) | 0.91 | 1.82 |
| MACD | 0.40 | 0.98 |
| Stochastic Oscillator | 94.64 | 97.03 |
Price Performance
Historical ComparisonAbout ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.